Navigation Links
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:3/4/2008

Keflex Product Sales Grow to $10.5 Million in 2007; MOXATAG, Company's Lead PULSYS Product, Approved Following Year-end; Process to Explore Strategic

Alternatives Ongoing

GERMANTOWN, Md., March 4 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced financial and operational results for the quarter and fiscal year ended December 31, 2007.

MiddleBrook reported fourth quarter 2007 revenue of $2.9 million, compared to revenue of $3.1 million in the third quarter of 2007 and $1.2 million in the fourth quarter of 2006. Revenue for the full year of 2007 increased to $10.5 million, up 117% from revenue of $4.8 million for the full year of 2006.

MiddleBrook reported research and development (R&D) expenses in the fourth quarter of $3.5 million, down from third quarter 2007 R&D expenses of $5.5 million and fourth quarter 2006 R&D expenses of $6.3 million. For the full year of 2007, R&D expenses declined to $22.0 million, from $26.0 million in R&D expenses for the full year of 2006.

Total operating expenses for the fourth quarter of 2007 were $9.8 million, down from $13.2 million in the third quarter of 2007 and $14.9 million in the fourth quarter of 2006. However, total expenses for the full year of 2007 increased slightly to $50.6 million, compared to total expenses of $48.2 million in 2006.

Net loss was $9.1 million for the fourth quarter, compared to a net loss of $10.1 million in the third quarter of 2007 and a net loss of $13.8 million in the fourth quarter of 2006. Net loss for the full year of 2007 was $42.2 million, compared to a net loss of $42.
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... Tenn. , Aug. 5, 2015 St. ... Zhang , Ph.D., as the first chair of the ... Jude Endowed Chair in Bioinformatics. Computational biology ... genomics, systems biology, biological image analysis and structural and ... in the Kay Research and Care Center, the newest ...
(Date:8/5/2015)... TRIANGLE PARK, N.C. , Aug. 5, ... company focused on cloud-based drug design and ... Genomeon, LLC, a startup genomic diagnostic and ... Cloud Pharmaceuticals to offer companion biomarkers as ... Cloud Pharmaceuticals can now access Genomeon,s ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... spectrometers are now compliant with the 21 CFR Part 11 electronic signature regulation ... confirms that the electronic records produced by Shimadzu’s EDX-7000/8000 are trustworthy and reliable ...
(Date:8/5/2015)... ... ... Knowledgent , the data and analytics firm, today announced a ... , Biopharmaceutical companies are seeing a surge in the amount of data generated and ... better position products in the market. , Data is being generated from two ...
Breaking Biology Technology:St. Jude Children's Research Hospital names Department of Computational Biology chair 2Cloud Pharmaceuticals and Genomeon Announce Marker Discovery and Drug Design Partnership 2Shimadzu's Energy Dispersive X-Ray Fluorescence Spectrometers Now Compliant With US FDA Electronic Signature Regulation 2New White Paper Explores How Big Data Enables Better Pharmacovigilance 2
... Revenue; Gross Margin Increase ... Continues; Net Losses Decline, IRVINE, ... device company focused on the development of,minimally invasive technologies for ... sales and procedures and,continued expense reductions in the three months ...
... SAN DIEGO, May 1 Vical Incorporated (Nasdaq:,VICL) today ... quarter ended March 31, 2008, before the opening of ... and webcast to discuss the,financial results and provide a ... The call is open on a listen-only basis to ...
... PRINCETON, N.J., May 1 Orchid Cellmark Inc.,(Nasdaq: ... testing,services, will release its first quarter 2008 financial results ... and is hosting a,conference call and webcast to discuss ... Management will discuss financial results for the first quarter,2008 ...
Cached Biology Technology:Endocare Reports 2008 First Quarter Financial Results 2Endocare Reports 2008 First Quarter Financial Results 3Endocare Reports 2008 First Quarter Financial Results 4Endocare Reports 2008 First Quarter Financial Results 5Endocare Reports 2008 First Quarter Financial Results 6Endocare Reports 2008 First Quarter Financial Results 7Endocare Reports 2008 First Quarter Financial Results 8Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Orchid Cellmark to Announce First Quarter 2008 Financial Results on May 8, 2008 2
(Date:8/5/2015)... , August 5, 2015 According ... Access Management Market by Software, Services, Vertical (BFSI, Airport, IT ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... Market globally into various segments. The global PIAM Market ... to $546.2 Million by 2019, at a CAGR of ...
(Date:8/5/2015)... New York , August 5, 2015 ... market report titled "Facial Recognition Market - Global Industry ... 2022", the global market for facial recognition is forecast ... is driven by increased demand for surveillance systems by ... the rising number of crimes and terrorist activities across ...
(Date:8/5/2015)... Calif. , Aug. 5, 2015 The ... continuous growth in applications, penetration into newer sectors, and ... year. The global biosensors space has seen the entry ... the market so far. (Photo - ... & Sullivan, Analysis of the Global Biosensors Market ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... can build its way to a more energy efficient future ... by improving the rules regulating these structures, according to ... Laboratory. PNNL scientists at the Joint Global Change Research ... Park, Md., have created a unique model that projects how ...
... Like little factories, cells metabolize raw materials and ... of this ability, using microorganisms to produce pharmaceuticals ... scale and create new types of chemicals, biotechnologists ... certain genes in the cell. But such metabolic ...
... have identified how a single gene in honey bees separates ... from Michigan State University and Wayne State University unraveled the ... issue of Biology Letters . The gene, which is ... in the evolution of bees, ability to carry pollen. ...
Cached Biology News:Modeling buildings by the millions: Building codes in China tested for energy savings 2Modeling buildings by the millions: Building codes in China tested for energy savings 3Modeling buildings by the millions: Building codes in China tested for energy savings 4A digital test for toxic genes 2A digital test for toxic genes 3Single gene separates queen from workers 2
... [EP282Y] to Asparagine synthetase ( ... applications). Antigen: ... residues in the C-terminus of ... Entrez GeneID: 440 ...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Anti-DDDDK-Tag (Enterokinase Cleavage Site), Agarose Conjugate Research Focus: tag Storage: 4C Shipping Temperature: 4C...
Biology Products: